-
摘要: 目的:探讨急性冠状动脉综合征(ACS)患者血清中介素(IMD)水平及临床意义。方法:选取ACS患者55例(ACS组),健康对照组30例,采用酶联免疫吸附试验检测血清IMD、超敏-C反应蛋白(hs-CRP)水平。依据冠脉造影结果评估冠脉狭窄程度,以Gensini积分总和表示。采用Pearson相关分析方法分析血清IMD水平与冠脉狭窄程度的相关性。结果:ACS组血清IMD、hs-CRP水平显著高于对照组 (均P<0.01),血清IMD与Gensini积分正相关(r=0.872,P＜0.01),ACS组血清IMD与hs-CRP呈正相关(r=0.650,P<0.01)。结论:ACS患者血清IMD水平升高,其水平与冠脉病变严重程度有关,IMD可能通过抗炎症发挥心肌保护作用,或可成为ACS诊断与危险评估有价值的生物标志物。Abstract: Objective:To examine the serum content of intermedin (IMD) and its clinical significance in patients with acute coronary syndrome (ACS). Method:The 55 acute coronary syndrome patients (ACS group,n=55) were enrolled in this study. Healthy individuals were employed as the control group (n=30). The serum levels of IMD and hs-CRP were determined by enzyme-linked immunosorbent assay. The severity of coronary artery stenosis in patients with ACS was measured by coronary angiography and expressed by the sum of Gensini scores. The correlation of IMD with the severity of coronary artery stenosis were analyzed with Pearson correlation analysis. Result:Serum IMD and hs-CRP levels were markedly higher in ACS patients than that in controls (both P<0.01). The increased serum IMD were positively correlated with Gensini scores(r=0.872,P<0.01). Serum IMD levels was positively correlated with hs-CRP(r=0.650,P<0.01).Conclusion:Plasma IMD levels are increased in patients with ACS, and associate with the severity of coronary artery stenosis. Cardio-protective effects of IMD is due to the inhibition of inflammatory, which can be a valuable biomarker in the diagnosis and assessment of ACS.
-
Key words:
- acute coronary syndrome /
- intermedin /
- high sensitive C-reactive protein
-
-
[1] GILARDI E,IACOMINI P,MARSILIANI D,et al.Biomarkers in the prediction and management of acute coronary syndromes:current perspectives[J].Res Reports Clin Cardiol,2014.doi:10.2147/RRCC.S36294
[2] NI X,ZHANG J,TANG C,et al.Intermedin/adrenomedullin2:an autocrine/paracrine factor in vascular homeostasis and disease[J].Sci China Life Scie,2014,57:781-789.
[3] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会.非ST段抬高急性冠状动脉综合征诊断和治疗指南[J].中华心血管病杂志,2012,40(5):353-367.
[4] YANG J H,QI Y F,JIA Y X,et al.Protective effects of intermedin/adrenomedullin 2on ischemia/reperfusion injury in isolated rat hearts[J].Peptides,2005,26:501-507.
[5] YANG X,ZHANG H,JIA Y,et al.Effects of intermedin1-53 on myocardial fibrosis[J].Acta Biochim Biophys Sin,2013,45:141-148.
[6] JIA Y X,YANG J H,PAN C S,et al.Intermedin1-53 protects the heart against isop roteren o-l induced ischemic injury in rats[J].Eur J Pharmacol,2006,549:117-123.
[7] SONG J Q,TENG X,CAI Y,et al.Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53)protection against myocardial apoptosis induced by ischemia/reperfusion[J].Apoptosis,2009,14:1299-1307.
[8] 杨靖辉,齐永芬,马存根.中叶素抑制大鼠心脏缺血/再灌注损伤[J].中国药理学通报,2008,24(5):592-596.
[9] MORRICE KW,BELL D,AGNEW C,et al.Intermedin and calcitonin gene-related peptide fail to shine in acute coronary syndrome[J].IJC Metab Endocr,2014,5:36-41.
[10] ZHANG X,GU LD,CHEN X P,et al.Intermedin ameliorates atherosclerosis in apoE null mice by modifying lipid profiles[J].Peptides,2012,37:189-193.
[11] DAI X Y,CAI Y,MAO D D,et al.Increased stability of phosphatase and tensin homolog by intermedinleading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice[J].Mol Cell Cardiol,2012,53:509-520.
[12] DAI X Y,CAI Y,SUN W,et al.Intermedin inhibits macrophage foam-cell formation via tristetraprolin-mediated decay of CD36 mRNA[J].Cardiovasc Res,2014,101:297-305.
[13] 杨靖辉,马存根,齐永芬.内源性中叶素可减轻血管紧张素Ⅱ诱导的乳鼠心肌细胞肥大[J].中国药理学通报,2012,28(1):83-87.
[14] TANG B,ZHONG Z,SHEN H W,et al.Intermedin as a prognostic factor for major adverse cardiovascular events in patients with ST-segment elevation acute myocardial infarction[J].Peptides,2014,58:98-102.
[15] LV Z,WU K,CHEN X,et al.Plasma intermedin levels in patients with acute myocardial infarction[J].Peptides,2013,43:121-125.
[16] 薛莉,李银萍,张辉.中介素对NF-κB介导的急性心肌梗死大鼠心室重构的影响[J].临床心血管病杂志,2013,29(10):789-791.
-
计量
- 文章访问数: 239
- PDF下载数: 171
- 施引文献: 0
下载: